Breakpoint Therapeutics aims to progress the scientific development of initial-in-class oncology medicines that interfere with DNA fix and replication strain tolerance pathways. The company’s therapeutics target the DNA harm response in cancer cells with repair service and replication worry tolerance pathways, enabling the medical organisation and hospitals to create medicines https://is.gd/VVmTMJ